2 citations
,
September 2021 in “Curēus” In this study, two patients with alopecia universalis continued using tofacitinib during active COVID-19 infection and showed no worsening of their illness, despite potential concerns about immunosuppression.
2 citations
,
October 2020 in “Annals of Oncology” This analysis discusses the role of genetic factors, particularly male hormones and specific gene variants, in influencing sex differences and potential susceptibility to severe COVID-19 outcomes, but notes that conclusive evidence is lacking, highlighting the need for larger studies.
2 citations
,
September 2013 in “Serbian Journal of Dermatology and Venereology” This study found a high prevalence of sexually transmitted infections, particularly anogenital warts and syphilis, among HIV-infected adults in Serbia, underscoring the importance of education on safe sex practices.
1 citations
,
January 2024 in “Annals of Dermatology” This study observed the clinical characteristics and treatment responses in patients who developed alopecia areata after COVID-19 infection or vaccination, highlighting the need for further research into the underlying pathogenesis and association.
1 citations
,
June 2023 in “BMC Pediatrics” In this prospective cohort study conducted in Iraq, 15.2% of children with confirmed COVID-19 experienced persistent symptoms beyond 12 weeks; common symptoms included fatigue and hair fall, with children aged 11-16 at greater risk.
1 citations
,
August 2022 in “American Journal of Tropical Medicine and Hygiene” This case report describes a 29-year-old man who developed scalp abscesses due to Mycobacterium abscessus infection after receiving scalp injections for hair loss, successfully treated with antibiotics.
1 citations
,
January 1996 This review discusses the rhizobia-legume interaction, focusing on infection thread formation and its relation to root hair and pollen tube growth, and reports no new experimental results; the authors call for more studies on early nodulins' role.
June 2026 in “Journal of Cutaneous and Aesthetic Surgery” In this case report, necrotic ulceration caused by Klebsiella pneumoniae at a pubic hair donor site was observed in a 52-year-old man following hair transplantation, highlighting the need for metabolic screening and culture-guided management to prevent complications in such procedures.
March 2026 in “Frontiers in Pediatrics” This case report documents a young girl who developed alopecia areata shortly after a COVID-19 infection, with significant hair regrowth achieved through topical treatment over six months, except for one resistant area; highlighting a potential link between the virus and autoimmune reactions.
December 2025 in “Reports — Medical Cases Images and Videos” This case report highlights the rarity and complex differential diagnosis of discoid lupus erythematosus, emphasizing that immunosuppressive therapy in such cases can lead to serious complications like pulmonary tuberculosis.
In this case study, a nine-year-old boy with alopecia universalis following severe chickenpox showed complete hair regrowth after treatment with tofacitinib, suggesting the drug's potential in managing varicella-zoster virus-induced alopecia by modulating immune responses.
February 2025 in “Indus journal of bioscience research.” In this descriptive cross-sectional study conducted at a Karachi hospital, researchers found a high prevalence of Telogen Effluvium in female COVID-19 survivors, particularly those with diabetes, and noted that dietary supplementation may be linked to reduced hair loss severity post-infection.
This study developed a high-performance deep learning model using the Inception-ResNet v2 architecture to classify 10 hair disease classes, achieving an accuracy of 94.7% and balanced precision, recall, and F1-scores of 0.94, suggesting reliability for automated dermatology diagnostics.
August 2024 in “Journal of Research in Clinical Medicine” In this study, researchers observed that patients with COVID-19 can develop a variety of skin lesions, with maculopapular rash, telogen effluvium, and urticaria showing significant associations with both the timing of symptom onset and the severity of the disease.
April 2024 in “Cell death and disease” This review discusses the long-term complications of COVID-19, known as long COVID or PASC, and emphasizes the need to improve awareness and management strategies but reports no new clinical findings.
January 2024 in “International Journal of Applied Research” In this cross-sectional study on Iraqis, 74.5% of participants self-reported hair loss following COVID-19 infection, with the highest prevalence among those aged 19-29, pointing to a potential link between COVID-19 and increased risk of telogen effluvium.
October 2023 in “Clinical Dentistry” This report describes two cases where alopecia areata occurred in conjunction with odontogenic infections, highlighting a mysterious association between dental infections and alopecia areata despite the known etiologies of the latter.
September 2023 in “JP Journal of Biostatistics” This study found that a random forest algorithm most effectively detected COVID-19, with high specificity and accuracy, among 10,862 individuals in an Iranian hospital setting.
June 2023 in “Pharmaceuticals” This review reports that sex-related differences in pharmacological response have been observed in SARS-CoV-2 infection, dyslipidemia, and diabetes mellitus, with implications for treatment strategies; for example, men may respond better to genomic vaccines for SARS-CoV-2, while women may benefit more from certain antiviral medications.
April 2023 in “Dermatology practical & conceptual” This study found that in female patients with COVID-19-related hair loss, diffuse hair loss and antinuclear antibody positivity might be linked to high antibody levels triggered by the infection.
February 2023 in “Vaccines” This review discusses the potential impact of COVID-19 on the male reproductive system and highlights unanswered questions regarding its mechanisms and implications for men's health and fertility, reporting no new clinical results.
January 2023 in “Sibirskij medicinskij vestnik” This analysis explores possible causes of menstrual irregularities in women with PCOS following COVID-19, but reports no new clinical findings.
December 2022 in “bioRxiv (Cold Spring Harbor Laboratory)” This study reported that an injectable hydrogel microparticle vaccine platform enhanced antibody responses and protection against influenza in mice, outperforming the traditional adjuvant aluminum hydroxide.
This study found that wavy sinus hairs in cats were significantly associated with feline leukemia virus infection, suggesting this physical trait might be useful for identifying infected cats.
May 2022 in “GLOBAL JOURNAL FOR RESEARCH ANALYSIS” This study found that 74.6% of COVID-19 patients in Prayagraj experienced telogen effluvium hair loss, predominantly affecting females.
March 2022 in “Berkala Ilmu Kesehatan Kulit dan Kelamin/Berkala ilmu kesehatan kulit dan kelamin (Periodical of dermatology and venerology)” This study found that nearly half of the tinea capitis patients at a Surabaya hospital had cat contact, with the most common symptoms being crust and hair loss.
January 2022 in “Journal of Drug Delivery and Therapeutics” This study reported that all ten COVID-19 patients experienced early onset of Telogen effluvium within three months of infection, after recovering without hospitalization.
December 2021 in “Consilium Medicum” This study found that treating diffuse alopecia associated with prior COVID-19 infection using a combination of Selencin (homeopathic drug) and Selencin Peptide Active (peptide lotion) significantly reduced hair loss and improved hair structure and volume in 34 patients over two months.
November 2021 in “Research Outreach” Low testosterone levels may lead to more severe COVID-19 outcomes.
October 2021 in “Utah State Research and Scholarship (Utah State University)” This study found that folic acid deficiency in infant mice moderately worsened rotaviral disease, while zinc deficiency did not significantly affect rotaviral disease progression.